Search results

• Prednisolone
  ...an activate and influence biochemical behaviour of most cells. The steroid/receptor complexes dimerise and interact with cellular DNA in the nucleus, binding t
  7 KB (872 words) - 16:41, 27 September 2010
• Ciprofloxacin
  ...INR should be monitored closely. They may also interact with the [[GABA A receptor]] and cause neurological symptoms; this effect is augmented by certain [[no
  88 KB (11,930 words) - 16:46, 27 September 2010
• Aspirin
  ...the experiments in rats, via the action on [[arachidonic acid]] and [[NMDA receptor]]s cascade.<ref name="Gutton">{{Cite journal|author=Guitton MJ, Caston J, R
  78 KB (10,918 words) - 16:52, 27 September 2010
• Atenolol
  ...enolol''' ('''Tenormin''') is a selective [[beta-1 receptor|β₁ receptor]] [[receptor_antagonist|antagonist]], a [[drug]] belonging to the group of ...lpha-agonists (e.g. [[clonidine]]), [[ACE Inhibitor]]s or [[Angiotensin II receptor antagonist]]s such as losartan can also be given additionally. Exert cautio
  12 KB (1,720 words) - 16:48, 27 September 2010
• Furosemide
  ...development, the &alpha;₆&beta;₂&gamma;₂ receptor increases in expression in cerebellar granule neurons, corresponding to inc
  12 KB (1,678 words) - 16:48, 27 September 2010
• Dopamine
  ...D₃]], [[Dopamine D4 receptor|D₄]], and [[Dopamine D5 receptor|D₅]]—and their variants. Dopamine is produced in several areas Via the [[dopamine receptor]]s, D_1-5, dopamine reduces the influence of the indirect pathway
  48 KB (6,470 words) - 16:48, 27 September 2010
• Timolol
  '''Timolol maleate''' is a non-selective [[beta blocker|beta-adrenergic receptor blocker]]. In its oral form ('''Blocadren'''), it is used to treat [[hypert
  4 KB (476 words) - 16:46, 19 September 2010
• Salbutamol
  ...short-acting [[beta2-adrenergic receptor agonist|β₂-adrenergic receptor agonist]] used for the relief of [[bronchospasm]] in conditions such as [[a Salbutamol was the first selective Β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys u
  15 KB (2,005 words) - 16:49, 27 September 2010
• Cortisol
  ...s Type I and Type II receptor agonist), or [[RU28362]] (a specific Type II receptor agonist), to adrenalectomized animals induced changes in [[leukocyte distri .... Aldosterone and cortisol have similar affinity for the mineralocorticoid receptor however, glucocorticoids circulate at roughly 100 times the level of minera
  41 KB (5,644 words) - 16:50, 27 September 2010
• Epinephrine
  {{See also|Adrenergic receptor}} ...ues. Its actions vary by tissue type and tissue expression of [[adrenergic receptor]]s. For example, epinephrine causes [[smooth muscle]] relaxation in the air
  22 KB (2,916 words) - 16:50, 27 September 2010
• Nitrous oxide
  ...and slightly potentiates [[GABAA receptor|GABA_A]] and [[glycine receptor]]s.<ref name="pmid11020766">{{cite journal|author = Yamakura T, Harris RA|t ...7862891}}</ref> Indeed, in humans given 30% N₂O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not a
  61 KB (8,728 words) - 16:50, 27 September 2010
• Morphine
  ...that apparently only reacted to morphine: the mu3 [[Opioid receptor|opiate receptor]] in human tissue.<ref>{{cite journal |author=Zhu W, Cadet P, Baggerman G, ...de release in the mammalian gastrointestinal tract via the micro(3) opiate receptor subtype: a hormonal role for endogenous morphine|journal=Journal of Physiol
  87 KB (12,376 words) - 16:51, 27 September 2010
• Diazepam
  ...inding to the benzodiazepine site on the [[GABAA receptor|GABA_A receptor]] leading to [[central nervous system]] depression.<ref name="Riss-2008"/> ...irst2 = R. | last3 = Hösl | first3 = K. | title = Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents? | url = http://www.springerlink.co
  78 KB (10,295 words) - 16:51, 27 September 2010
• Template:Antiarrhythmic agents
  |group2 = [[Receptor (biochemistry)|Receptor]] [[agonist]]s<BR>and [[Receptor antagonist|antagonist]]s | group5 = [[adenosine A1 receptor|A1 agonist]]
  3 KB (298 words) - 12:09, 19 September 2010
• Template:Cholinergics
  | group1 = [[Acetylcholine receptor|Receptor]] [[ligand]]s | group1 = [[Muscarinic acetylcholine receptor|mAChR]]
  13 KB (792 words) - 12:11, 19 September 2010
• Template:Serotonergics
  | group1 = [[5-HT1 receptor|5-HT₁ receptor]] [[ligand]]s | group2 = [[5-HT2 receptor|5-HT₂ receptor]] ligands
  26 KB (1,619 words) - 22:18, 21 September 2010
• Template:Antidepressants
  | group2 = [[Receptor antagonist|Receptor antagonist]]s and/or [[Reuptake inhibitor|reuptake inhibitor]]s ...ne]]s and other [[5-HT1A receptor|5-HT_1A receptor]] [[Serotonin receptor agonist|agonist]]s
  13 KB (1,038 words) - 16:53, 27 September 2010
• Template:Antimigraine preparations
  | group2 = [[Serotonin receptor agonist|5-HT1 agonists]]
  2 KB (183 words) - 16:42, 19 September 2010
• Template:Drugs for obstructive airway diseases
  | group8 = [[Thromboxane receptor antagonist]]s
  2 KB (191 words) - 12:10, 19 September 2010
• Template:Major drug groups
  ...}} ''[[renin-angiotensin system]]'' ([[ACE inhibitor]]s, [[Angiotensin II receptor antagonist]]s, [[Renin inhibitor]]s) ...}} [[Fertility medication|Fertility agents]]{{•}} [[Selective estrogen receptor modulator|SERM]]s{{•}} [[Sex steroid|Sex hormones]]
  5 KB (556 words) - 19:23, 27 September 2011

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)